Regenerative Medicine (Bone and Joint) Market to Witness Robust Growth Supported by Rising Prevalence of Musculoskeletal Disorders

The regenerative medicine (bone and joint) market has witnessed significant growth over recent years. Regenerative medicine allows the repair, replacement or regeneration of damaged, diseased or aging cells, tissues or organs. In bone and joint applications, regenerative medicine is used to treat conditions such as bone fractures, arthrodesis, delayed union & non-union of bone fracture, osteochondral defects, cruciate ligament injury, meniscus tears, degenerative arthritis and joint replacement revision cases. Rising prevalence of musculoskeletal disorders along with growing geriatric population vulnerable to osteoarthritis and other joint disorders has increased the demand for bone graft substitutes and orthobiologics.

The Global regenerative medicine (bone and joint) Market is estimated to be valued at US$ 10494.33 Mn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.




Get More Insights On Regenerative Medicine Market


https://www.exoltech.us/blogs/....247615/Regenerative-